Agios Pharmaceuticals (AGIO) Change in Acquisitions & Divestments (2012 - 2026)

Agios Pharmaceuticals' Change in Acquisitions & Divestments history runs 15 years deep, the most recent figure standing at $290.3 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 0.7% year-over-year to $290.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 40.3% YoY) and the FY2025 annual result came in at $1.0 billion, up 26.26% from the prior year.
• Change in Acquisitions & Divestments was $290.3 million for Q1 2026 at Agios Pharmaceuticals, up from $252.3 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $368.7 million in Q1 2024 and bottomed at $141.9 million in Q2 2024.
• A 5-year average of $233.1 million and a median of $220.6 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments jumped 147.84% — and 2023, when it plunged 55.06%.
• Agios Pharmaceuticals' Change in Acquisitions & Divestments stood at $198.9 million in 2022, then slipped by 6.38% to $186.2 million in 2023, then declined by 19.36% to $150.1 million in 2024, then surged by 68.03% to $252.3 million in 2025, then grew by 15.06% to $290.3 million in 2026.
• Business Quant data shows AGIO's Change in Acquisitions & Divestments at $290.3 million in Q1 2026, $252.3 million in Q4 2025, and $272.1 million in Q3 2025.